Inactive Instrument

Analyst Reco. Flamel Technologies S.A. (ADR) Nasdaq

Equities

US3384881096

End-of-day quote Nasdaq Other stock markets
- ^USD	-

Apr. 25	European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading	MT
Apr. 23	European Equities Traded in the US as American Depositary Receipts Jump in Tuesday Trading	MT

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Craig-Hallum Adjusts Avadel Pharmaceuticals' Price Target to $22 From $20, Maintains Buy Rating	Mar. 05	MT
HC Wainwright Raises Price Target on Avadel Pharmaceuticals to $25 From $21, Maintains Buy Rating	Mar. 05	MT
Piper Sandler Raises Price Target on Avadel Pharmaceuticals to $23 From $18, Maintains Overweight Rating	Mar. 05	MT
Needham Adjusts Avadel Pharmaceuticals' Price Target to $22 From $20, Keeps Buy Rating	Mar. 05	MT
Oppenheimer Adjusts Avadel Pharmaceuticals Price Target to $29 From $27, Maintains Outperform Rating	Mar. 05	MT
UBS Initiates Avadel Pharmaceuticals With Buy Rating, $21 Price Target	Feb. 06	MT
Oppenheimer Raises Price Target on Avadel Pharmaceuticals to $27 From $25, Maintains Outperform Rating	Jan. 09	MT
Needham Adjusts Price Target on Avadel Pharmaceuticals to $20 From $19, Keeps Buy Rating	Dec. 20	MT
HC Wainwright Adjusts Avadel Pharmaceuticals Price Target to $21 From $17.50, Maintains Buy Rating	23-07-05	MT
Oppenheimer Adjusts Avadel Pharmaceuticals Price Target to $25 From $22, Maintains Outperform Rating	23-06-30	MT
Ladenburg Thalmann Adjusts Price Target on Avadel Pharmaceuticals to $16 From $14.50, Maintains Buy Rating	23-05-02	MT
HC Wainwright Adjusts Price Target on Avadel Pharmaceuticals to $17.50 From $14, Maintains Buy Rating	23-05-02	MT
Needham Adjusts Price Target on Avadel Pharmaceuticals to $14 From $12, Maintains Buy Rating	23-05-02	MT
Oppenheimer Adjusts Avadel Pharmaceuticals Price Target to $22 From $20, Maintains Outperform Rating	23-05-02	MT
Possibility of US Fed's Rate Hike Pause Supports American Depositary Receipts of European Equities	23-03-23	MT
HC Wainwright Adjusts Price Target on Avadel Pharmaceuticals to $14 From $13, Keeps Buy Rating	23-03-23	MT
American Depositary Receipts of European Equities Advance Slightly Before US Rate Decision	23-03-22	MT
Oppenheimer Adjusts Avadel Pharmaceuticals' Price Target to $20 From $19, Maintains Outperform Rating	23-02-27	MT
ECB, Bank of England Interest Rate Hikes Weigh Down European Equities	22-12-15	MT
Jefferies Upgrades Avadel Pharmaceuticals to Buy From Hold, Raises Price Target to $11 From $6.50	22-11-30	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Flamel Technologies S.A. (ADR) Nasdaq

Equities

US3384881096

Analyst Reco.

Filters